So-called “smart drugs” meant to enhance brain performance are more likely to leave users ineffectually spinning in place, a new study has found. These stimulants, typically used to treat ADHD, increased study participants’ motivation in solving problems. But the subjects also took much longer to complete tasks because they acted in a more erratic, scattershot manner while they worked, researchers reported in the journal Science Advances. For example, participants on the ADHD drug methylphenidate (Ritalin) took around 50% longer on average to complete a “knapsack task” than they did when they took a placebo, results showed. In this task, subjects are asked to figure out the most efficient way to fill a knapsack to a certain capacity, using a selection of items with various weights. “Although the use of these kinds of stimulant drugs in people without ADHD may be increasing their motivation in complex problem-solving tasks, they decrease the quality of the solutions, so their productivity is decreased,” said lead researcher Elizabeth Bowman, a neuroscientist at the University of Melbourne Centre for Brain, Mind and Markets in Australia. Students and white-collar workers have increasingly turned to prescription stimulants in an attempt to increase their productivity, said Pat Aussem, vice president of consumer clinical content development for the Partnership to End Addiction. Essentially, they are a modern-day spin on the caffeine pills that college students… read on > read on >

















